Needle-Free Devices: Technologies and Global Markets

Report Highlights

The global market for needle-free devices should grow from $3.0 billion in 2018 to $4.6 billion by 2023, increasing at a compound annual growth rate (CAGR) of 9.3% from 2018 to 2023.

Report Includes

• 36 data tables and 34 additional tables
• Detailed overview of the global markets for needle-free devices and technologies within the industry
• Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
• Country specific data and analysis for United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, South Korea, Middle East and Africa
• Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
• Insight into various needle-free technologies that are used in drug delivery and their various application areas
• A look at the government regulations that can affect the global needle-free devices market
• Identification of the competitive landscape of the market with the leading market players, suppliers and pharmaceutical partners
• Profiles of major vendor companies, including 3M, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC (GSK), Medtronic, Merck Serono S.A., and Teva Pharmaceutical Industries Ltd.

Report Scope

This report provides a detailed description of needle-free devices and the latest technologies in the market. The report includes market estimates for different types of needle-free devices. The report also includes recent technological developments and assessments of product performance in the market.

Based on the product type, the global needle-free device market is segmented into Needle-free Injectors, Inhaler technologies, Transdermal patch technologies and Other novel technologies (e.g., microneedles and pen needles).

Based on the application, the global needle-free device market is segmented into Pain management, Vaccine delivery, Insulin delivery and Pediatric drug delivery.

The report includes a list of marketed and pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing market growth. The market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the global needle-free device market, as well as the competition in the global needle-free device market and the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes on the company profiles of major vendors including company overview, key product offerings, financial statistics, and other developments. The report also provides insights on the market share and upcoming regional demand for the needle-less technologies.

Some of the major market players discussed in the report are 3M, Antares Pharma AG, Medtronic, Novartis and Teva Pharmaceuticals. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Hydrogen Fuel Cell: Global Markets (EGY186B)
• Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)
• Single-use Technologies for Biopharmaceuticals: Global Markets (BIO099F)
• Induced Pluripotent Stem Cells: Global Markets (BIO135F)
• Commercial Amino Acids (BIO007N)